1) Unfortunately, another negative result for immunoadsorption for Long Covid.
A small trial that focused only on patients with elevated levels of antibodies against β1/β2-adrenergic and/or M3/M4-muscarinic acetylcholine receptors found no improvement in objective outcomes.
